Hospira Recalls Magnesium Sulfate Injection Due to pH Specification Failure
Hospira Inc. is recalling 106,900 vials of Magnesium Sulfate Injection, USP, 50% because 12-month stability testing failed pH specifications.
- Product
- Magnesium Sulfate Injection, USP, 50%, 20mL, Single dose Fliptop Vial, For IV or IM use, Rx only, Manufactured by Hospira, Inc. 4285 Wesleyan Blvd Rocky Mount, NC 27804 for Hospira, Inc. 275 N Field Drive, Lake Forest, IL 60045. NDC 0409-2168-02
- Category
- Drug
- Distribution
- Distributed nationwide